EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Outcomes and physiologic responses associated with ketamine administration after traumatic brain injury in the United States and Canada: a retrospective analysis

Austin J Peters iD, Saad A Khan iD, Seiji Koike iD, Susan Rowell iD, Martin Schreiber iD

Journal of Trauma and Injury · 2023

DOI: 10.20408/jti.2023.0034 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Trauma and Injury, 2023. Verfasst von Austin J Peters und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology and Perioperative Medicine, Oregon Health & Science University, Portland, OR, USA. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NHLBI NIH HHS, NCATS NIH HHS, National Heart, Lung, and Blood Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Ketamine has historically been contraindicated in traumatic brain injury (TBI) due to concern for raising intracranial pressure. However, it is increasingly being used in TBI due to the favorable respiratory and hemodynamic properties. To date, no studies have evaluated whether ketamine administered in subjects with TBI is associated with patient survival or disability.

Methods

We performed a retrospective analysis of data from the multicenter Prehospital Tranexamic Acid Use for Traumatic Brain Injury trial, comparing ketamine-exposed and ketamine-unexposed TBI subjects to determine whether an association exists between ketamine administration and mortality, as well as secondary outcome measures.

Results

We analyzed 841 eligible subjects from the original study, of which 131 (15.5%) received ketamine. Ketamine-exposed subjects were younger (37.3±16.9 years vs. 42.0±18.6 years, P=0.037), had a worse initial Glasgow Coma Scale score (7±3 vs. 8±4, P=0.003), and were more likely to be intubated than ketamine-unexposed subjects (88.5% vs. 44.2%, P

Schlagwörter

Stichwörter der Autor:innen

BiomarkersGlial fibrillary acidic proteinIntracranial pressureKetamineTraumatic brain injuries

Autor:innen und Institutionen

  • Department of Anesthesiology and Perioperative Medicine, Oregon Health & Science University, Portland, OR, USA.
  • Creighton University School of Medicine, Omaha, NE, USA.
  • Biostatistics and Design Program, Oregon Health & Science University, Portland, OR, USA.
  • Department of Surgery, Section of Trauma, University of Chicago Medicine, Chicago, IL, USA.
  • Donald D. Trunkey Center for Civilian and Combat Casualty Care, Oregon Health & Science University, Portland, OR, USA.

ORCID-Profile: Austin J Peters, Saad A Khan, Seiji Koike, Susan Rowell, Martin Schreiber

Förderung

  • NHLBI NIH HHS
  • NCATS NIH HHS
  • National Heart, Lung, and Blood Institute
  • Defense Medical Research and Development Program

Zitieren

APA

Peters, A. J., Khan, S. A., Koike, S., Rowell, S., & Schreiber, M. (2023). Outcomes and physiologic responses associated with ketamine administration after traumatic brain injury in the United States and Canada: a retrospective analysis. Journal of Trauma and Injury. https://doi.org/10.20408/jti.2023.0034

Vancouver

Peters AJ, Khan SA, Koike S, Rowell S, Schreiber M. Outcomes and physiologic responses associated with ketamine administration after traumatic brain injury in the United States and Canada: a retrospective analysis. Journal of Trauma and Injury. 2023. doi:10.20408/jti.2023.0034

BibTeX
@article{Peters2023,
  author = {Peters, Austin J and Khan, Saad A and Koike, Seiji and Rowell, Susan and Schreiber, Martin},
  title = {Outcomes and physiologic responses associated with ketamine administration after traumatic brain injury in the United States and Canada: a retrospective analysis},
  journal = {Journal of Trauma and Injury},
  year = {2023},
  doi = {10.20408/jti.2023.0034}
}
Kostenlos starten →